Table 1 Participant characteristics at baseline (N = 115)

From: Digital humanistic program to manage premature frailty in young breast cancer survivors with gender perspective

Characteristics

Control group (n = 55)

ITT group (n = 60)

Value

Value

P value

Age (years), mean (SD)

40.02 (4.32)

40.40 (4.16)

0.68

Height (cm), mean (SD)

160.55 (4.36)

161.76 (4.12)

0.19

Weight (kg), mean (SD)

55.37 (7.51)

56.43 (9.61)

0.57

Diagnosis (years), mean (SD)

1.00 (0.61)

1.08 (0.56)

0.45

Residence, n (%)

  

0.62

 Urban

48 (87.3)

55 (91.7)

 

 Rural

7 (12.7)

5 (8.3)

 

Marital status, n (%)

  

0.74

 Married

51 (92.7)

53 (88.3)

 

 Single

3 (5.5)

5 (8.3)

 

 Other

1 (1.8)

2 (3.4)

 

Child, n (%)

  

0.62

 Have

52 (94.5)

56 (93.3)

 

 Do not have

3 (5.5)

4 (6.7)

 

Parent, n (%)

  

0.99

 Both

46 (83.6)

48 (80.0)

 

 Either

7 (12.7)

11(18.3)

 

 Neither

2 (3.7)

1 (1.7)

 

Work status, n (%)

  

0.95

 Unemployed

19 (34.5)

18 (30.0)

 

 Employed

36 (63.5)

42 (70.0)

 

Education level, n (%)

  

0.60

\({\boldsymbol{\le }}\)Junior college

24 (43.6)

33 (55.0)

 

 College

26 (47.3)

23 (38.3)

 

 Postgraduate

5 (9.1)

4 (6.7)

 

Monthly income (CNY ¥), n (%)

  

0.57

 <5000

11 (20.0)

11 (18.3)

 

 5000–10,000

15 (27.3)

17 (28.3)

 

 >10,000

29 (52.7)

32 (53.4)

 

Type of breast cancer, n (%)

  

0.45

 Invasive

51 (92.7)

58 (96.7)

 

 Noninvasive

4 (7.3)

2 (3.3)

 

Stage of breast cancer, n (%)

  

0.13

 Stage I

19 (34.5)

21 (35)

 

 Stage II

30 (54.5)

28 (46.7)

 

 Stage III

6 (11.0)

11 (8.3)

 

Therapy for breast cancer, n (%)

  

0.34

 Operation

5 (9.1)

8 (13.3)

 

aAdjuvant therapy

26 (47.3)

23 (38.4)

 

 Both

24 (43.6)

29 (48.3)

 
  1. aNot limited to radiotherapy, chemotherapy, endocrine therapy, etc.